ConsoneAI
ConsoneAI is a TechBio company revolutionizing drug development and chemical safety by leveraging AI and computational models to predict chemical toxicity. Their product, DioScor, uses deep learning and a curated toxicity database of over 80,000 compounds to predict patient outcomes from preclinical to clinical stages, focusing on organism-level toxicity. The platform reduces reliance on animal testing, supports regulatory compliance, and accelerates drug development by enabling early toxicity identification, reducing costs, and improving success rates. ConsoneAI targets pharmaceutical, biotech, academia, and investors, aiming to enhance safety, efficacy, and sustainability in drug development.
ConsoneAI
ConsoneAI is a TechBio company revolutionizing drug development and chemical safety by leveraging AI and computational models to predict chemical toxicity. Their product, DioScor, uses deep learning and a curated toxicity database of over 80,000 compounds to predict patient outcomes from preclinical to clinical stages, focusing on organism-level toxicity. The platform reduces reliance on animal testing, supports regulatory compliance, and accelerates drug development by enabling early toxicity identification, reducing costs, and improving success rates. ConsoneAI targets pharmaceutical, biotech, academia, and investors, aiming to enhance safety, efficacy, and sustainability in drug development.